GLP-1 surgery warning
Patients have been advised to carefully manage pre-surgery fasting with professionals, especially amid the rise in unapproved peptide use The increasing popularity of glucagon-like peptide-1 receptor agonists (GLP-1s) and other …
‘Terminated’: DBG Health cuts ties with accused
The wellness empire, backed by pharmaceuticals entrepreneur Dennis Bastas, has made changes to one of its brands after charges were laid against a fitness personality Dennis Bastas’ DBG Health has …
‘Deliberately dishonest’: Former pharmacist fined for falsifying records
The Queensland-based former pharmacist admitted to changing records eight times for ADHD medicines, tribunal papers show A former pharmacist has been fined $5000 and reprimanded for creating false clinical records …
Pharmacist trial data falls short: RACGP
Doctors have criticised a recent review of a Tasmanian UTI prescribing pilot, claiming the evaluation doesn’t take into account benefits and risks The Royal Australian College of General Practitioners (RACGP) …
Banner group pulls Andrographis products
Products have been stripped from the market voluntarily after the medicines regulator received a high number of severe allergy reports TerryWhiteChemmart (TWC) says it has voluntarily recalled two products containing …
Workforce issues key barrier to scope expansion: Tassie pilot
Patients were complimentary of service standards, but pharmacists reported costs, time and remuneration still stand in the way of expanded scope, a review found A review of a year-long Tasmanian …
Lessons from pharmacist influencers
Pharmacists with large online followings share their words of wisdom for other professionals, including how to protect patients, deal with pushback and adhere to regulations If you have an audience …
‘Not a big enough saving to cut out my pharmacist’
As one pharmaceutical giant announced plans to sideline bricks-and-mortar pharmacies and go direct to customers, patients have joined a chorus of voices questioning the plans – and savings Plans to …
Infinity ‘has been a disappointment for us’: Paragon
The wholesaler was owed $48.5m at the end of the financial year and says it still plans to recoup some of the funds, including ‘rigorously’ pursuing directors Paragon Care says …
Peptide boom poses ‘growing risk’ to businesses: lawyers
Pharmacists may start to see more patients who have sourced peptides online, which could have implications for medication management and risk, specialists warn Pharmacists and compounders “should consider whether their …
‘Perceived conflict of interest’: Doctors renew Vic scope objections
GPs and specialists want the state government to rethink pharmacist prescribing powers for OCPs, arguing revenue models could disincentivise referral for first-line options Expanded contraceptive prescribing in retail pharmacy settings …
CWH trio’s wealth dips: Richest 250 list
Shifting sands have seen a “major shake up” in The Australian’s wealth list, with pharmacy juggernauts among those whose positions have changed Some of the wealthiest people in Australia have …